{"id":727,"date":"2024-08-29T15:19:26","date_gmt":"2024-08-29T19:19:26","guid":{"rendered":"https:\/\/gp2stg.wpenginepowered.com\/?page_id=727"},"modified":"2024-11-12T11:49:34","modified_gmt":"2024-11-12T16:49:34","slug":"gp2-novel-gba1-webinar","status":"publish","type":"page","link":"https:\/\/gp2.org\/fr\/gp2-novel-gba1-webinar\/","title":{"rendered":"GP2 Novel GBA1 Webinar"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>GP2 Novel GBA1 Webinar Through the first-of-its-kind genome-wide study of 1,488 people with PD and 196,430 control volunteers, investigators\u00a0identified a novel variant in\u00a0GBA1\u00a0that increases the risk of Parkinson\u2019s disease among people of African and African admixed populations. On June 29, 2023, GP2 representatives presented the findings to the broader research community. Watch the recording below [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-727","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/pages\/727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/comments?post=727"}],"version-history":[{"count":0,"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/pages\/727\/revisions"}],"wp:attachment":[{"href":"https:\/\/gp2.org\/fr\/wp-json\/wp\/v2\/media?parent=727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}